168 related articles for article (PubMed ID: 21802908)
1. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation.
Hansali F; Poisson G; Wu M; Bendedouch D; Marie E
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):332-8. PubMed ID: 21802908
[TBL] [Abstract][Full Text] [Related]
2. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants.
Wu M; Dellacherie E; Durand A; Marie E
Colloids Surf B Biointerfaces; 2009 Feb; 69(1):141-6. PubMed ID: 19147334
[TBL] [Abstract][Full Text] [Related]
3. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants.
Wu M; Dellacherie E; Durand A; Marie E
Colloids Surf B Biointerfaces; 2009 Feb; 69(1):147-51. PubMed ID: 19027270
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion.
Huang CY; Chen CM; Lee YD
Int J Pharm; 2007 Jun; 338(1-2):267-75. PubMed ID: 17368981
[TBL] [Abstract][Full Text] [Related]
6. Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography.
Bootz A; Russ T; Gores F; Karas M; Kreuter J
Eur J Pharm Biopharm; 2005 Aug; 60(3):391-9. PubMed ID: 15996580
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles.
Reddy LH; Murthy RR
Acta Pharm; 2004 Jun; 54(2):103-18. PubMed ID: 15274754
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
10. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
11. Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain.
Lin Y; Pan Y; Shi Y; Huang X; Jia N; Jiang JY
Nanotechnology; 2012 Apr; 23(16):165101. PubMed ID: 22460562
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion.
Weiss CK; Lorenz MR; Landfester K; Mailänder V
Macromol Biosci; 2007 Jul; 7(7):883-96. PubMed ID: 17595680
[TBL] [Abstract][Full Text] [Related]
13. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
14. On inverse miniemulsion polymerization of conventional water-soluble monomers.
Capek I
Adv Colloid Interface Sci; 2010 Apr; 156(1-2):35-61. PubMed ID: 20199767
[TBL] [Abstract][Full Text] [Related]
15. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.
Bootz A; Vogel V; Schubert D; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):369-75. PubMed ID: 15018998
[TBL] [Abstract][Full Text] [Related]
16. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles.
Hekmatara T; Gelperina S; Vogel V; Yang SR; Kreuter J
J Nanosci Nanotechnol; 2009 Aug; 9(8):5091-8. PubMed ID: 19928187
[TBL] [Abstract][Full Text] [Related]
18. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging.
Fokong S; Siepmann M; Liu Z; Schmitz G; Kiessling F; Gätjens J
Ultrasound Med Biol; 2011 Oct; 37(10):1622-34. PubMed ID: 21924206
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
20. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
